GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (BSP:B1GN34) » Definitions » Inventories, Raw Materials & Components

BeiGene (BSP:B1GN34) Inventories, Raw Materials & Components : R$785 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BeiGene Inventories, Raw Materials & Components?

BeiGene's inventories, raw materials & components for the quarter that ended in Mar. 2024 was R$785 Mil.

BeiGene's quarterly raw materials increased from Sep. 2023 (R$464 Mil) to Dec. 2023 (R$729 Mil) and increased from Dec. 2023 (R$729 Mil) to Mar. 2024 (R$785 Mil).

BeiGene's annual raw materials increased from Dec. 2021 (R$442 Mil) to Dec. 2022 (R$467 Mil) and increased from Dec. 2022 (R$467 Mil) to Dec. 2023 (R$729 Mil).


BeiGene Inventories, Raw Materials & Components Historical Data

The historical data trend for BeiGene's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeiGene Inventories, Raw Materials & Components Chart

BeiGene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 99.45 441.87 466.62 728.95

BeiGene Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 565.94 529.29 464.39 728.95 785.49

BeiGene Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


BeiGene (BSP:B1GN34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (BSP:B1GN34) » Definitions » Inventories, Raw Materials & Components
Address
c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108
BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

BeiGene (BSP:B1GN34) Headlines

No Headlines